Search Results for: cronos

0 194

Cronos Group Appoints James Holm as Chief Financial Officer

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”), an innovative global cannabinoid…

 Leave a comment    Posted in Uncategorized
0 179

Cronos Group Reports 2022 Third Quarter Results

Reported consolidated net revenue increased 3% year-over-year to $20.9 million; on a constant currency basis,…

 Leave a comment    Posted in Uncategorized
0 119

Cronos Group Reports 2022 Second Quarter Results

Consolidated net revenue increased by 48% year-over-year to $23.1 million in Q2 2022 Israel net…

 Leave a comment    Posted in Uncategorized
0 240

Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022…

 Leave a comment    Posted in Uncategorized
0 394

Cronos Group Inc. to Hold 2022 First Quarter Earnings Conference Call on May 10, 2022

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos” or the “Company”) will hold its 2022…

 Leave a comment    Posted in Uncategorized
0 548

Cronos Group Reports 2021 Fourth Quarter and Full-Year Results

Consolidated net revenue increased 59% in Full Year 2021 compared to Full Year 2020 Announces…

 Leave a comment    Posted in Uncategorized
0 1163

Cronos Group Inc. to Hold 2021 Fourth Quarter and Full-Year Earnings Conference Call on March 1, 2022

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”) will hold its…

 2 Comments    Posted in Uncategorized
0 693

Cronos Group Reports 2021 Third Quarter Results

Completed Audit Committee evaluation and restated Q2 2021 unaudited interim financial statements Announces strategic realignment…

 Leave a comment    Posted in Uncategorized
0 321

Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group

Aurora Cannabis Inc. (NASDAQ: ACB) (TSX: ACB) (“Aurora”), the Canadian company defining the future of cannabinoids worldwide,…

 Leave a comment    Posted in Uncategorized
0 312

Aurora and 22nd Century Group License Foundational Biosynthesis IP to Cronos Group

Aurora Cannabis Inc. (NASDAQ | TSX: ACB) (“Aurora”), the Canadian company defining the future of…

 Leave a comment    Posted in Uncategorized